Market Overview:
The global pacemakers market is expected to reach USD 10.5 billion by 2030, registering a CAGR of 5.1% during the forecast period 2018-2030. The implantable cardiac pacemakers segment is expected to dominate the market in terms of revenue share and is projected to grow at a CAGR of 5.2% during the forecast period. The external cardiac pacemakers segment is projected to grow at a CAGR of 4.8%. Hospitals are estimated to be the largest end user for pacemakers in 2018 and are expected to register a CAGR of 5%, while ambulatory surgery centers (ASCs) are estimated to be the fastest growing end user with a CAGR of 6%.
Product Definition:
A pacemaker is a small, battery-operated device that's surgically implanted under the skin in your upper chest. It helps control abnormal heart rhythms by sending electrical impulses to your heart.
Implantable Cardiac Pacemakers:
Implantable cardiac pacemakers are a group of devices used to treat bradycardia and heart blockage. They consist of an implantable battery-powered generator that produces electrical signals to the heart muscle to initiate and maintain normal sinus rhythm.
External Cardiac Pacemakers:
External cardiac pacemakers are devices that help in the treatment of bradycardia and tachycardia. They are used to increase the rate or decrease the rate of heartbeats. These devices can be either permanent or temporary depending on their usage.
Application Insights:
The clinics segment dominated the global pacemakers market in 2017 and is expected to witness significant growth over the forecast period. Increasing number of clinical trials and initiatives by key industry players are some of the major factors driving this segment. For instance, in June 2016, Medtronic launched a new version - Vivoactive HR - which includes built-in heart rate monitor for tracking heart rate during exercise. This feature was previously available only with advanced cardiac pacemakers such as ICDs. Such technological advancements are expected to drive demand for external cardiac pace makers at clinics over the forecast period.
The hospitals segment is also anticipated to witness considerable growth owing to increasing prevalence of cardiovascular diseases (CVDs) globally coupled with rising awareness about advanced cardiac devices among healthcare professionals worldwide.
Regional Analysis:
North America dominated the global pacemakers market in 2017. The presence of well-established healthcare infrastructure, favorable reimbursement policies, and increasing awareness among patients are some of the factors responsible for this dominance. In addition, growing adoption of advanced technologies such as MRI compatible pacemakers is expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the next eight years owing to rising geriatric population base and improving economic conditions in emerging countries such as China and India. Moreover, a large number of people suffering from cardiac disorders are also contributing towards market growth due to high unmet needs regarding replacement surgeries in these countries which will further boost revenue generation opportunities for industry players operating within APAC region during the forecast period.
Growth Factors:
- Increasing prevalence of cardiovascular diseases (CVDs) is the major growth driver for pacemakers market. According to World Health Organization (WHO), CVDs are the leading cause of death globally, accounting for 31% of all global deaths in 2012. This number is projected to reach 43% by 2030.
- Rising geriatric population is also a key growth driver for pacemakers market as incidence of CVDs increases with age. According to United Nations Department of Economic and Social Affairs Population Division, world’s geriatric population (aged 60 years or above) was 841 million in 2017 and is expected to reach 2 billion by 2050.
- Technological advancements in pacemaker devices are also propelling the growth of this market worldwide. For instance, recently FDA has approved Abbott’s Ellipse ICD which offers a number of advanced features such as full-body MRI scanning and atrial fibrillation detection capabilities .
Scope Of The Report
Report Attributes
Report Details
Report Title
Pacemakers Market Research Report
By Type
Implantable Cardiac Pacemakers, External Cardiac Pacemakers
By Application
Hospitals, ASCs, Clinics
By Companies
Boston Scientific, Medtronic, Cardiac Science, CCC Medical Devices, Cook Medical, GE Healthcare, MEDICO, SORIN GROUP, ZOLL Medical Corporation, Boston Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
220
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Pacemakers Market Report Segments:
The global Pacemakers market is segmented on the basis of:
Types
Implantable Cardiac Pacemakers, External Cardiac Pacemakers
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, ASCs, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- Medtronic
- Cardiac Science
- CCC Medical Devices
- Cook Medical
- GE Healthcare
- MEDICO
- SORIN GROUP
- ZOLL Medical Corporation
- Boston Scientific
Highlights of The Pacemakers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Implantable Cardiac Pacemakers
- External Cardiac Pacemakers
- By Application:
- Hospitals
- ASCs
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pacemakers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A pacemaker is a small, battery-operated device that helps to regulate the heart rate. It is often used to treat conditions such as atrial fibrillation (a type of irregular heartbeat) or ventricular tachycardia (an abnormally high heart rate).
Some of the major companies in the pacemakers market are Boston Scientific, Medtronic, Cardiac Science, CCC Medical Devices, Cook Medical, GE Healthcare, MEDICO, SORIN GROUP, ZOLL Medical Corporation, Boston Scientific.
The pacemakers market is expected to register a CAGR of 5.1%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pacemakers Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pacemakers Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pacemakers Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pacemakers Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pacemakers Market Size & Forecast, 2020-2028
4.5.1 Pacemakers Market Size and Y-o-Y Growth
4.5.2 Pacemakers Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Implantable Cardiac Pacemakers
5.2.2 External Cardiac Pacemakers
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 ASCs
6.2.3 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pacemakers Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pacemakers Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Implantable Cardiac Pacemakers
9.6.2 External Cardiac Pacemakers
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 ASCs
9.10.3 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Implantable Cardiac Pacemakers
10.6.2 External Cardiac Pacemakers
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 ASCs
10.10.3 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Implantable Cardiac Pacemakers
11.6.2 External Cardiac Pacemakers
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 ASCs
11.10.3 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Implantable Cardiac Pacemakers
12.6.2 External Cardiac Pacemakers
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 ASCs
12.10.3 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Implantable Cardiac Pacemakers
13.6.2 External Cardiac Pacemakers
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 ASCs
13.10.3 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pacemakers Market: Competitive Dashboard
14.2 Global Pacemakers Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific
14.3.2 Medtronic
14.3.3 Cardiac Science
14.3.4 CCC Medical Devices
14.3.5 Cook Medical
14.3.6 GE Healthcare
14.3.7 MEDICO
14.3.8 SORIN GROUP
14.3.9 ZOLL Medical Corporation
14.3.10 Boston Scientific
